Friberg Gregory R
Biomarin Pharmaceutical Inc · NASDAQ
−4,086 sh · $245.2K
BlackRock
13F filer
$1.87B
22,738,349 sh
Dodge & Cox
13F filer
$849.4M
14,844,930 sh
Viking Global Investors
13F filer
$435.8M
7,616,563 sh
Renaissance Technologies
13F filer
$57.9M
1,024,871 sh
Bridgewater Associates
13F filer
$11.7M
206,911 sh
Two Sigma Investments
13F filer
$2.5M
44,475 sh
Plenge Robert M
US insider
—
6,140 sh
Friberg Gregory R
Biomarin Pharmaceutical Inc · NASDAQ
−4,086 sh · $245.2K
Plenge Robert M
Biomarin Pharmaceutical Inc · NASDAQ
+6,140 sh
Davis George Eric
Biomarin Pharmaceutical Inc · NASDAQ
−17,557 sh · $1.2M
Dodge & Cox
Biomarin Pharmaceutical Inc · NASDAQ
14,844,930 sh · $849.4M
Viking Global Investors
Biomarin Pharmaceutical Inc · NASDAQ
7,616,563 sh · $435.8M
Dodge & Cox
Biomarin Pharmaceutical Inc · NASDAQ
14,561,759 sh · $822.6M
Two Sigma Investments
Biomarin Pharmaceutical Inc · NASDAQ
44,475 sh · $2.5M
Bridgewater Associates
Biomarin Pharmaceutical Inc · NASDAQ
206,911 sh · $11.7M
Renaissance Technologies
Biomarin Pharmaceutical Inc · NASDAQ
1,024,871 sh · $57.9M
Viking Global Investors
Biomarin Pharmaceutical Inc · NASDAQ
7,062,077 sh · $398.9M